10/03/2023

Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19

Abstract

BACKGROUND

Early treatment to prevent severe coronavirus disease 2019 (Covid-19) is an important component of the comprehensive response to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic.

Matéria original

Anterior

Monoclonal antibodies: a remedial approach to prevent SARS-CoV-2 infection
Próxima

Endoplasmic reticulum secretory pathway: Potential target against SARS-CoV-2